fls.txt
We have no plans, and undertake no obligation, to revise or update our forward-looking statements to reflect any event or circumstance that may arise after the date of this Quarterly Report on Form 10-Q.


item1.txt
In certain instances, the Company’s indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make.
During the three months ended March 29, 2019, the Company paid $141.5 million (including commissions) in connection with the repurchase of 1.7 million shares of its common stock (paying an average price of $81.57 per share).
The Company adopted ASU 2018-15, on a prospective basis, during the second quarter of fiscal 2019.
1 to such Annual Report on Form 10-K, filed with the SEC on January 25, 2019 (the “2018 10-K”).
The deemed repatriation tax is payable over the next seven years, $18.0 million per year for each of the next four years, followed by payments of $33.6 million, $44.9 million, and $56.1 million in years five through seven, respectively.
The Company tests its goodwill for impairment annually as of the first day of its fourth fiscal quarter and in interim periods if certain events occur indicating the carrying value of goodwill may be impaired.
This newly authorized stock repurchase plan replaces in its entirety the January 31, 2018, stock repurchase program.
This ASU provides guidance that changes the accounting for income tax effects of intra-entity transfers of assets other than inventory.
In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740), Intra-entity Transfers of an Asset Other than Inventory (“ASU 2016-16”).
The impact from the cumulative effect adjustment was not material and comparative information for prior periods has not been adjusted.
In certain instances, the Company’s indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make.
To date, there have been no material impairment losses on accounts receivable.
Refer to Note 2, Revenue Recognition, for additional information.
On January 30, 2019, the Board of Directors approved a stock repurchase program, pursuant to which the Company is authorized to repurchase up to $2.0 billion of its common stock from time to time prior to January 30, 2021, on the open market or in privately negotiated transactions, as permitted by securities laws and other legal requirements.
In connection with certain facility leases, the Company has indemnified its lessors for certain claims arising from the facility or the lease.
These BEAT provisions are effective for the Company beginning in fiscal 2019.
The Company adopted ASU 2018-15, on a prospective basis, during the second quarter of fiscal 2019.


item2.txt
The increase in research and development expenses for the three and six months ended March 29, 2019, as compared with the corresponding periods in fiscal 2018, was primarily related to an increase in employee-related compensation expense and product development–related expenses.
We generated net revenue of $810.4 million for the three months ended March 29, 2019, a decrease of $103.0 million or 11.3%, as compared with $913.4 million for the corresponding period in fiscal 2018.
This report and other documents we have filed with the SEC contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the “safe harbor” created by those sections.
The decrease in selling, general and administrative expenses for the three and six months ended March 29, 2019, as compared with the corresponding periods in fiscal 2018, was primarily related to a decrease in share-based compensation expense.
Research and development expense increased as a percentage of net revenue, when compared with the corresponding periods in fiscal 2018, as a result of our increased investment in developing new technologies and products, as well as the decline in revenue.
During the six months ended March 29, 2019, we generated $741.1 million of cash from operating activities, a decrease of $53.9 million as compared with the $795.0 million generated during the six months ended March 30, 2018.
The decrease in selling, general and administrative expenses for the three and six months ended March 29, 2019, as compared with the corresponding periods in fiscal 2018, was primarily related to a decrease in share-based compensation expense.


item3.txt
We are subject to overall financial market risks, such as changes in market liquidity, credit quality, investment risk, interest rate risk, and foreign exchange rate risk as described below.
A percentage of our international operational expenses are denominated in foreign currencies and exchange rate volatility could positively or negatively impact those operating costs.


item4.txt
Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.


part2.txt
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
There have been no material changes from the risk factors previously disclosed in the 2018 10-K.


